Marshalko O V, Konorev M R
Klin Med (Mosk). 2008;86(2):43-8.
The predictive value of gastric metaplasia in the duodenal mucosa in patients Helicobacter pylori-positive patients with duodenal bulb ulcer (DBU) was investigated. One hundred and twenty four randomly selected patients with DBU were included in this prospective study. The detection of Helicobacter pylori (HP) in the stomach and duodenum was carried out with Giemsa (using standard visual analogue scale), rapid urease test (standard Jatrox-HP test, Rohm Pharma, Germany), and polymerase chain reaction (PCR) to detect the specific fragment of ureC HP gene (Helicopol II, Lytech, Russia). Regions of gastric metaplasia of the duodenum were confirmed by periodic acid-Schiff and alcian blue (Serva) staining (pH 1.0; 2.5) Duodenal ulcer (DU) complications were registered within 8 to 10 years. Estimation of the predictive factor (gastric metaplasia in the duodenum) was carried out in patients with non-complicated DU (Group 1; n = 73), and with such complications as bleeding, perforation, penetration, pyloroduodenal stenosis (Group 2; n = 51) which were revealed within the 8 to 10 years of observation. Gastric metaplasia in the duodenum was found in 64 or 87.7% of the 73 patients with non-complicated DU and in 5 or 9.8% of the 51 patients with complicated DU within 8 to 10 years of observation. The following facts about the predictive factor for the prognosis of DU complication were found: the sensitivity of 83.6%, the specificity of 92.8%, the predictive accuracy of 88.7%, the relative risk of the predicted outcome of 7.5, the relative risk of a different outcome of 0.11, the odds ration of 65.4. The study revealed a high and significant (p < 0.001) predictive value of gastric metaplasia in the duodenum as a marker of non-complicated clinical course of DU in HP-positive patients within an 8 to 10-year period.
对幽门螺杆菌阳性的十二指肠球部溃疡(DBU)患者十二指肠黏膜胃化生的预测价值进行了研究。124例随机选取的DBU患者纳入了这项前瞻性研究。采用吉姆萨染色(使用标准视觉模拟量表)、快速尿素酶试验(标准Jatrox-HP试验,德国罗姆制药公司)以及聚合酶链反应(PCR)检测胃和十二指肠中的幽门螺杆菌(HP),以检测ureC HP基因的特异性片段(Helicopol II,俄罗斯Lytech公司)。十二指肠胃化生区域通过过碘酸希夫和阿尔辛蓝(德国Serva公司)染色(pH 1.0;2.5)得以确认。在8至10年内记录十二指肠溃疡(DU)并发症情况。对未并发DU的患者(第1组;n = 73)以及在8至10年观察期内出现出血、穿孔、穿透、幽门十二指肠狭窄等并发症的患者(第2组;n = 51)的预测因素(十二指肠胃化生)进行了评估。在8至10年观察期内,73例未并发DU的患者中有64例(87.7%)发现十二指肠胃化生,51例并发DU的患者中有5例(9.8%)发现十二指肠胃化生。发现了以下关于DU并发症预后预测因素的事实:敏感性为83.6%,特异性为92.8%,预测准确性为88.7%,预测结果的相对风险为7.5,不同结果的相对风险为0.11,优势比为65.4。该研究揭示,在8至10年期间,十二指肠胃化生作为幽门螺杆菌阳性患者未并发DU临床病程的标志物具有高度且显著(p < 0.001)的预测价值。